Pros and Cons of Ampio Pharmaceuticals Inc. in the next few years
Pros
?
C******** o* t** e**********
?
M***** P*******
?
B****
Cons
?
S********** s********
?
G***** c******* t* c**********
?
W********* I********* f** t** n*** y****
Tell us your opinion to access the 'Wisdom of the Crowds'
Performance of Ampio Pharmaceuticals Inc. vs. its peers
Security | Change(%) | 1w | 1m | 1y | YTD | 3y | 5y |
---|---|---|---|---|---|---|---|
Ampio Pharmaceuticals Inc. | - | - | - | - | - | - | - |
Celsion Corp. | - | -6.475% | 8.333% | 17.117% | 118.487% | -90.877% | -94.964% |
India Globalization Capital | -8.410% | -4.608% | -6.757% | 71.074% | 58.015% | -64.433% | -56.695% |
Protara Therapeutics Inc. | 1.490% | 3.906% | -2.920% | -5.674% | 60.241% | -65.897% | - |
Comments
Ampio Pharmaceuticals, Inc. (NYSE: AMPE) is now covered by analysts at StockNews.com. They set a "sell" rating on the stock.
Show more
Ratings data for AMPE provided by MarketBeat
Ampio Pharmaceuticals, Inc. (NYSE: AMPE) is now covered by analysts at StockNews.com. They set a "sell" rating on the stock.
Show more
Ratings data for AMPE provided by MarketBeat
Ampio Pharmaceuticals, Inc. (NYSE: AMPE) is now covered by analysts at StockNews.com. They set a "sell" rating on the stock.
Show more
Ratings data for AMPE provided by MarketBeat